Protagonist Therapeutics, Inc: net_income
| Value | {"amount": -125550748, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Protagonist Therapeutics, Inc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:14:38.425290+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fda7b2ce-7111-4f64-a247-d7313b61e44c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-26-050429Retrieved: 2026-08-19T13:14:38.425290+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001377121/net-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fda7b2ce-7111-4f64-a247-d7313b61e44c
History
- supersedes {"amount": -125551000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001558370-22-002385)